|
A multicenter retrospective analysis of nivolumab in advanced melanoma during the French Temporary Authorization Use. |
| |
|
No Relationships to Disclose |
| |
|
|
Research Funding - Bristol-Myers Squibb (Inst) |
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD |
| |
|
No Relationships to Disclose |
| |
|
Consulting or Advisory Role - Bristol-Myers Squibb; Merck Serono; MSD; Novartis (Inst); Roche |
| |
|
No Relationships to Disclose |
| |
|
Honoraria - Bristol-Myers Squibb; MSD; Novartis; Roche |
Consulting or Advisory Role - Bristol-Myers Squibb; Incyte; MSD; Novartis; Roche |
Research Funding - Bristol-Myers Squibb (Inst); MSD (Inst); Novartis (Inst); Roche (Inst) |
Expert Testimony - Bristol-Myers Squibb; MSD; Novartis; Roche |
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Roche |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
Speakers' Bureau - Bristol-Myers Squibb; Roche |
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Roche |
| |
|
No Relationships to Disclose |
| |
|
Employment - Bristol-Myers Squibb |
Stock and Other Ownership Interests - Bristol-Myers Squibb |
Speakers' Bureau - Bristol-Myers Squibb |
Travel, Accommodations, Expenses - Bristol-Myers Squibb |
Other Relationship - Bristol-Myers Squibb |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |